We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CLGN market cap is 17.05M. The company's latest EPS is USD -1.4500 and P/E is -0.98.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 98k | 249k | 4k | 164k | 2.06M |
| Operating Income | -4.33M | -4.41M | -4.54M | -3.97M | -1.65M |
| Net Income | -4.2M | -4.21M | -4.33M | -3.88M | -1.45M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.14M | 15.64M | 299k | 10.96M | 515k |
| Operating Income | -5.6M | 65k | -17.1M | -7.51M | -17.25M |
| Net Income | -5.77M | 237k | -16.93M | -7.02M | -16.61M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.29M | 26.57M | 22.44M | 18.71M | 17.21M |
| Total Liabilities | 5.85M | 5.84M | 5.52M | 5.25M | 4.81M |
| Total Equity | 24.45M | 20.73M | 16.92M | 13.47M | 12.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.84M | 51.22M | 37.77M | 34.13M | 18.71M |
| Total Liabilities | 6.36M | 6.1M | 5.49M | 5.79M | 5.25M |
| Total Equity | 4.48M | 45.12M | 32.28M | 28.34M | 13.47M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.25M | -7.18M | -10.63M | -14.09M | -1.17M |
| Investing | -82k | -341k | -481k | -539k | -8k |
| Financing | 9k | 9k | 9k | 9k | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.45M | 2.5M | -13.7M | -2.76M | -14.09M |
| Investing | -519k | -31.56M | 28.92M | -1.16M | -539k |
| Financing | 4.47M | 38.76M | 1.87M | 1.11M | 9k |
| Market Cap | 17.05M |
| Price to Earnings Ratio | -0.98 |
| Price to Sales Ratio | 31.56 |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | 1.21 |
| Dividend Yield | - |
| Shares Outstanding | 11.45M |
| Average Volume (1 week) | 96.85k |
| Average Volume (1 Month) | 241.31k |
| 52 Week Change | -70.29% |
| 52 Week High | 5.48 |
| 52 Week Low | 1.42 |
| Spread (Intraday) | 0.18 (11.76%) |
| Company Name | CollPlant Biotechnologies Ltd |
| Address |
4 oppenheimer rehovot, center 7670104 |
| Website | https://www.collplant.com |
| Industry | real estate (6500) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
